Lyme Disease - Direct and Indirect Panel Test in Ashland, Kentucky
The Lyme Disease - Direct and Indirect Panel panel contains 2 tests with 16 biomarkers.
Lyme Disease - Direct and Indirect Panel
Both indirect (Serology) and direct tests (PCR) should be routinely used for the accurate, sensitive, and specific laboratory detection of Lyme disease. Because of the complex nature of the disease, no single test is adequate for all clinical situations.
The diagnosis of Lyme disease is most often made by clinical examination combined with evidence of tick bite or exposure in endemic areas. Amplification of Borrelia genomic DNA from blood, fluids or tissues can support the diagnosis.
Lyme disease is transmitted by a tick vector carrying Borreliaburgdorferi. Immunoblot testing qualitatively examines, with high specificity, antibodies in a patient's specimen. Immunoblot testing is appropriate for confirming a detected EIA or IFA test result.